ArticleAmerican journal of clinical pathology2022

VS38c and CD38-Multiepitope Antibodies Provide Highly Comparable Minimal Residual Disease Data in Patients With Multiple Myeloma.

Annemiek Broijl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.